Facilities

 

UZ College of Health Sciences: The HRTP is well positioned to benefit from the institutional progress that has been made through the UZ MEPI. Dr. Morse, the D43 principal investigator, was invited to be the chair of the UZ MEPI Training Advisory Committee in 2012. Dr. Morse attended the MEPI retreat and participated in extensive presentations and discussions with the MEPI faculty and investigators. This participation has solidified the UB-UZ HRTP collaboration creating a synergistic environment that facilitates research mentoring within both programs and has led to new multidisciplinary research projects. This approach creates a vision of how these two programs can identify research areas that are of mutual interest and this will lead to joint grant applications and efficient program development within the UZ College of Health Sciences.

Biomedical Research and Training Institute (BRTI), International Clinical Operational and Health Systems Research Training Award (ICOHRTA) is funded to support the African Program for Research Training in HIV and TB, a joint program of BRTI and Stanford within Zimbabwe. This program is different in that it does not provide mentored research training as the HRTP does but does benefit the UB-UZ HRTP by providing auxiliary research support resources. Access to both programs has helped our prior fellows and facilitated the leveraging of projects to obtain additional support from ICOHRTA.

University of California (UC) Berkeley HRTP: UC Berkeley offers training for international scholars in AIDS-related research through support from their HRTP with an emphasis in epidemiology and public health. An example of an individual who benefited from this collaboration is Mr. Samuel Gavi, a UB-UZ HRTP fellow who also completed a Master’s degree at Berkeley. As a result of this complementary training Samuel is now a junior UZ faculty member and a resource for the UB-UZ HRTP trainees in the area of study design and data analysis. Through conversations with Dr. Reingold (PI: UC Berkeley HRTP), we have developed plans for an integrated approach for UB-UZ HRTP trainees to receive joint mentoring during visits and teleconferencing while in the US, or through collaborative workshops offered in Zimbabwe.

Kings College London maintains a behavioral health focus of many initiatives through its collaboration with the UZ CHS at Parirenyatwa Hospital. Within the Parirenyatwa Opportunistic Infection Clinic, Kings College London has created an opportunity to foster collaboration among externally funded research training programs. As one example, a multidisciplinary research team has been formed to investigate behavioral aspects of patient retention and medication adherence.

UZ-University of California San Francisco (UCSF) NIAID AIDS Clinical Trials Site (CTS) conducts protocols for the NIH HIV Research Networks (ACTG, IMPAACT, HPTN, MTN and VTN) and offers opportunities for HRTP faculty and fellows to collaborate and benefit from CTS mentors. The HRTP is also integral to the ACTG-supported International Pharmacology Specialty Laboratory at UZ, its partnership with the UZ CTS, and the training received by young scientists, laboratory technologists and data managers who contribute to UZ research. 

University of Rochester (UR) Center for AIDS Research (CFAR) is a NIAID CFAR, and Dr. Morse (D43 PI), is a senior investigator in the UR CFAR. The UR CFAR recently facilitated an international supplement application for one of the UB-UZ HRTP fellows, who successfully competed and is conducting a study of maternal and neonatal hair tenofovir concentrations to quantitate maternal and neonatal pharmacokinetics during pregnancy, respectively. The UR CFAR director and co-director are members of the UB-UZ HRTP Scientific Advisory Board.